Cannon Christopher P. (ed.) Management of Acute Coronary Syndromes

2nd edition. — Humana Press, 2003. — 798 p. — (Contemporary Cardiology) — ISBN: 978-1-58829-130-1In this second edition of his highly acclaimed book, Christopher P. Cannon, MD, and a team of preeminent clinical investigators have thoroughly revised and expanded every chapter to reflect the recent explosion of clinical trials on the management of acute coronary syndromes (ACS). These world-renowned experts review: the newer tests, such as C reactive protein; a multimarker approach to diagnosis and risk stratification; new antiplatelet agents; and combinations of thrombolytic-anti- thrombotic regimens. They also discuss the latest developments in interventional cardiology (early invasive approach in higher risk ACS patients and the promise of drug-coated stents), and analyze cost-effectiveness in clinical trials to choose appropriate therapies. Current trial data are included, along with practical recommendations on how these data may be applied in daily practice. Comprehensive and authoritative, Management of Acute Coronary Syndromes, Second Edition, succinctly presents cardiologists, internists, primary care and emergency physicians, fellows, and residents with an up-to-the-minute review of the many recent advances that have transformed our understanding of the pathophysiology, diagnosis, and management of patients with acute coronary syndromes.Pathophysiology
The Spectrum of Myocardial Ischemia
Linking Biochemistry, Vascular Biology, and Clinical Events in Acute Coronary Syndromes
Triggers of Acute Coronary Syndromes
Insights into the Pathophysiology of Acute Ischemic Syndromes Using the TIMI Flow Grade, TIMI Frame Count, and TIMI Myocardial Perfusion Grade
Diagnosis
Emergency Department Presentations of Acute Cardiac Ischemia
Early Identification and Treatment of Patients with Acute Coronary Syndromes
Serum Markers for Diagnosis and Risk Stratification in Acute Coronary Syndromes
Technologies to Diagnose Acute Ischemia
ST-Segment Elevation Myocardial Infarction
Thrombolytic Therapy
Primary Angioplasty
Expanding the Access to Percutaneous Coronary Intervention for Patients Admitted to Community Hospitals
Antiplatelet and Anticoagulant Therapy
β-Adrenergic Blockers, Calcium Channel Blockers, and Nitrates
Angiotensin Converting Enzyme Inhibitors After and During Acute Coronary Syndromes, and, in Particular, Myocardial Infarction
Risk Stratification
Non-ST-Segment Elevation Myocardial Infarction
Anticoagulant Therapies
Antiplatelet Therapy
Thrombolytics and Invasive vs Conservative Strategies in Unstable Angina
Current Device Strategies in the Management of Acute Coronary Syndromes
Special Aspects of Acute Coronary Syndromes
Women and Acute Coronary Syndromes
The Modern Strategy for Cardiogenic Shock
Myocardial Infarction in the Younger Patient
Cholesterol Lowering
“Secondary Prevention” of Myocardial Infarction
Cost and Cost-Effectiveness in Acute Coronary Syndromes
Smoking Cessation
Critical Pathways for Acute Coronary Syndromes